A 0 1 0 1 O
leukemia 2 10 2 10 B-cancer
specific 11 19 11 19 O
phenotype 20 29 20 29 B-clinical_variable
post 30 34 30 34 I-clinical_variable
transplant 35 45 35 45 I-clinical_variable
at 46 48 46 48 I-clinical_variable
a 49 50 49 50 I-clinical_variable
level 51 56 51 56 I-clinical_variable
of 57 59 57 59 O
≥ 60 61 60 61 O
0.01 62 66 62 66 B-lower_bound
% 66 67 66 67 I-lower_bound

AST 0 3 68 71 B-clinical_variable
≤ 4 5 72 73 O
3 6 7 74 75 B-upper_bound
times 8 13 76 81 I-upper_bound
the 14 17 82 85 I-upper_bound
upper 18 23 86 91 I-upper_bound
limit 24 29 92 97 I-upper_bound
of 30 32 98 100 I-upper_bound
normal 33 39 101 107 I-upper_bound

An 0 2 108 110 O
immune 3 9 111 117 O
globulin 10 18 118 126 O
rearrangement 19 32 127 140 O
known 33 38 141 146 O
to 39 41 147 149 O
be 42 44 150 152 O
a 45 46 153 154 O
disease 47 54 155 162 O
marker 55 61 163 169 O
for 62 65 170 173 O
this 66 70 174 178 O
patient 71 78 179 186 O
post 79 83 187 191 O
transplant 84 94 192 202 B-treatment

Any 0 3 203 206 O
leukemia 4 12 207 215 B-cancer
specific 13 21 216 224 O
marker 22 28 225 231 O
( 29 30 232 233 O
such 30 34 233 237 O
as 35 37 238 240 O
t(9:22 38 44 241 247 O
) 44 45 247 248 O
or 46 48 249 251 O
t(4:11 49 55 252 258 O
) 55 56 258 259 O
) 56 57 259 260 O
documented 58 68 261 271 O
in 69 71 272 274 O
the 72 75 275 278 O
patient 76 83 279 286 O
's 83 85 286 288 O
leukemia 86 94 289 297 O
cells 95 100 298 303 O
pre 101 104 304 307 B-treatment
transplant 105 115 308 318 I-treatment
on 116 118 319 321 O
a 119 120 322 323 O
post 121 125 324 328 B-treatment
transplant 126 136 329 339 I-treatment
evaluation 137 147 340 350 I-treatment

Any 0 3 351 354 O
patient 4 11 355 362 O
regardless 12 22 363 373 O
of 23 25 374 376 O
sex 26 29 377 380 O
or 30 32 381 383 O
age 33 36 384 387 B-age
with 37 41 388 392 O
CD19 42 46 393 397 B-cancer
+ 46 47 397 398 I-cancer
B 48 49 399 400 I-cancer
- 49 50 400 401 I-cancer
ALL 50 53 401 404 I-cancer
undergoing 54 64 405 415 O
allogeneic 65 75 416 426 B-treatment
HSCT 76 80 427 431 I-treatment
( 81 82 432 433 O
Group 82 87 433 438 O
A 88 89 439 440 O
) 89 90 440 441 O

Available 0 9 442 451 O
allogeneic 10 20 452 462 B-treatment
activated 21 30 463 472 I-treatment
peripheral 31 41 473 483 I-treatment
blood 42 47 484 489 I-treatment
T 48 49 490 491 I-treatment
cell 50 54 492 496 I-treatment
products 55 63 497 505 I-treatment
with 64 68 506 510 O
> 69 70 511 512 O
= 70 71 512 513 O
15 71 73 513 515 B-lower_bound
% 73 74 515 516 I-lower_bound
expression 75 85 517 527 O
of 86 88 528 530 O
CD19.CAR 89 97 531 539 O
- 97 98 539 540 O
CD28ζ 98 103 540 545 O
determined 104 114 546 556 O
by 115 117 557 559 O
flow 118 122 560 564 B-clinical_variable
cytometry 123 132 565 574 I-clinical_variable
( 133 134 575 576 O
cell 134 138 576 580 O
dose 139 143 581 585 O
is 144 146 586 588 O
based 147 152 589 594 O
on 153 155 595 597 O
total 156 161 598 603 O
cell 162 166 604 608 O
numbers 167 174 609 616 O
and 175 178 617 620 O
not 179 182 621 624 O
individual 183 193 625 635 O
antileukemic 194 206 636 648 O
cell 207 211 649 653 O
numbers 212 219 654 661 O
) 219 220 661 662 O

Bilirubin 0 9 663 672 B-clinical_variable
≤ 10 11 673 674 O
2 12 13 675 676 B-upper_bound
times 14 19 677 682 I-upper_bound
the 20 23 683 686 I-upper_bound
upper 24 29 687 692 I-upper_bound
limit 30 35 693 698 I-upper_bound
of 36 38 699 701 I-upper_bound
normal 39 45 702 708 I-upper_bound

Currently 0 9 709 718 O
taking 10 16 719 725 O
corticosteroids 17 32 726 741 B-treatment
( 33 34 742 743 O
> 34 35 743 744 O
0.5 35 38 744 747 B-lower_bound
mg 39 41 748 750 I-lower_bound
/ 41 42 750 751 I-lower_bound
kg 42 44 751 753 I-lower_bound
/ 44 45 753 754 I-lower_bound
day 45 48 754 757 I-lower_bound
prednisone 49 59 758 768 B-treatment
or 60 62 769 771 O
equivalent 63 73 772 782 O
) 73 74 782 783 O
for 75 78 784 787 O
therapy 79 86 788 795 B-treatment
of 87 89 796 798 O
GVHD 90 94 799 803 B-chronic_disease

Estimated 0 9 804 813 B-clinical_variable
GFR 10 13 814 817 I-clinical_variable
> 14 15 818 819 O
50 16 18 820 822 B-lower_bound
mL 19 21 823 825 I-lower_bound
/ 21 22 825 826 I-lower_bound
min 22 25 826 829 I-lower_bound

Evidence 0 8 830 838 O
of 9 11 839 841 O
GVHD 12 16 842 846 B-clinical_variable
> 17 18 847 848 O
grade 19 24 849 854 B-lower_bound
II 25 27 855 857 I-lower_bound

Group 0 5 858 863 O
A 6 7 864 865 O
: 7 8 865 866 O
CD19 9 13 867 871 O
+ 13 14 871 872 O
B 15 16 873 874 B-cancer
- 16 17 874 875 I-cancer
ALL 17 20 875 878 I-cancer
undergoing 21 31 879 889 O
allogeneic 32 42 890 900 O
HSCT 43 47 901 905 B-treatment
or 48 50 906 908 O
Group 51 56 909 914 O
B 57 58 915 916 O
: 58 59 916 917 O
CD19 60 64 918 922 O
+ 64 65 922 923 O
B 66 67 924 925 B-cancer
cell 68 72 926 930 I-cancer
CLL 73 76 931 934 I-cancer
or 77 79 935 937 O
NHL 80 83 938 941 B-cancer
undergoing 84 94 942 952 O
allogeneic 95 105 953 963 O
HSCT 106 110 964 968 O

Hgb 0 3 969 972 B-clinical_variable
≥ 4 5 973 974 O
7.0 6 9 975 978 B-lower_bound
( 10 11 979 980 O
can 11 14 980 983 O
be 15 17 984 986 O
a 18 19 987 988 O
transfused 20 30 989 999 O
value 31 36 1000 1005 O
) 36 37 1005 1006 O

History 0 7 1007 1014 O
of 8 10 1015 1017 O
hypersensitivity 11 27 1018 1034 O
reactions 28 37 1035 1044 O
to 38 40 1045 1047 O
murine 41 47 1048 1054 B-allergy_name
protein 48 55 1055 1062 I-allergy_name
- 55 56 1062 1063 I-allergy_name
containing 56 66 1063 1073 I-allergy_name
products 67 75 1074 1082 I-allergy_name

Karnofsky 0 9 1083 1092 B-clinical_variable
/ 9 10 1092 1093 I-clinical_variable
Lansky 10 16 1093 1099 I-clinical_variable
score 17 22 1100 1105 I-clinical_variable
≥ 23 24 1106 1107 O
50 25 27 1108 1110 B-lower_bound
% 27 28 1110 1111 I-lower_bound

Life 0 4 1112 1116 B-clinical_variable
expectancy 5 15 1117 1127 I-clinical_variable
of 16 18 1128 1130 O
≥12 19 22 1131 1134 O
weeks 23 28 1135 1140 I-lower_bound

Life 0 4 1141 1145 B-clinical_variable
expectancy 5 15 1146 1156 I-clinical_variable
≥ 16 17 1157 1158 O
6 18 19 1159 1160 B-lower_bound
weeks 20 25 1161 1166 I-lower_bound

Mixed 0 5 1167 1172 O
donor 6 11 1173 1178 O
chimerism 12 21 1179 1188 B-chronic_disease
( 22 23 1189 1190 O
any 23 26 1190 1193 O
level 27 32 1194 1199 O
) 32 33 1199 1200 O

No 0 2 1201 1203 O
other 3 8 1204 1209 B-treatment
investigational 9 24 1210 1225 I-treatment
antitumor 25 34 1226 1235 I-treatment
therapy 35 42 1236 1243 I-treatment
for 43 46 1244 1247 O
one 47 50 1248 1251 B-upper_bound
month 51 56 1252 1257 I-upper_bound
prior 57 62 1258 1263 I-upper_bound
to 63 65 1264 1266 O
entry 66 71 1267 1272 O
in 72 74 1273 1275 O
this 75 79 1276 1280 O
study 80 85 1281 1286 O

Patient 0 7 1287 1294 O
has 8 11 1295 1298 O
an 12 14 1299 1301 O
appropriate 15 26 1302 1313 O
donor 27 32 1314 1319 O
identified 33 43 1320 1330 O
for 44 47 1331 1334 O
hematopoietic 48 61 1335 1348 B-treatment
stem 62 66 1349 1353 I-treatment
cell 67 71 1354 1358 I-treatment
transplantation 72 87 1359 1374 I-treatment

Pregnant 0 8 1375 1383 B-pregnancy
or 9 11 1384 1386 O
lactating 12 21 1387 1396 O

Pulse 0 5 1397 1402 B-clinical_variable
oximetry 6 14 1403 1411 I-clinical_variable
of 15 17 1412 1414 O
> 18 19 1415 1416 O
90 20 22 1417 1419 B-lower_bound
% 22 23 1419 1420 I-lower_bound
on 24 26 1421 1423 O
room 27 31 1424 1428 O
air 32 35 1429 1432 O

Residual 0 8 1433 1441 B-cancer
disease 9 16 1442 1449 I-cancer
at 17 19 1450 1452 O
the 20 23 1453 1456 O
time 24 28 1457 1461 O
of 29 31 1462 1464 O
transplant 32 42 1465 1475 B-treatment
( 43 44 1476 1477 O
bulky 44 49 1477 1482 O
or 50 52 1483 1485 O
minimal 53 60 1486 1493 O
) 60 61 1493 1494 O
or 62 64 1495 1497 O
post 65 69 1498 1502 B-treatment
transplant 70 80 1503 1513 I-treatment
relapse 81 88 1514 1521 O
as 89 91 1522 1524 O
evidenced 92 101 1525 1534 O
by 102 104 1535 1537 O
PCR 105 108 1538 1541 O
positivity 109 119 1542 1552 O
, 119 120 1552 1553 O
specific 121 129 1554 1562 O
cytogenetic 130 141 1563 1574 O
abnormalities 142 155 1575 1588 O
, 155 156 1588 1589 O
an 157 159 1590 1592 O
abnormal 160 168 1593 1601 O
population 169 179 1602 1612 O
on 180 182 1613 1615 O
flow 183 187 1616 1620 B-treatment
cytometry 188 197 1621 1630 I-treatment
or 198 200 1631 1633 O
increased 201 210 1634 1643 O
blasts 211 217 1644 1650 O
on 218 220 1651 1653 O
bone 221 225 1654 1658 B-treatment
marrow 226 232 1659 1665 I-treatment
biopsy 233 239 1666 1672 I-treatment
or 240 242 1673 1675 O
in 243 245 1676 1678 O
the 246 249 1679 1682 O
peripheral 250 260 1683 1693 O
blood 261 266 1694 1699 O

Severe 0 6 1700 1706 O
intercurrent 7 19 1707 1719 O
infection 20 29 1720 1729 B-chronic_disease

Sexually 0 8 1730 1738 O
active 9 15 1739 1745 O
patients 16 24 1746 1754 O
must 25 29 1755 1759 O
be 30 32 1760 1762 O
willing 33 40 1763 1770 B-contraception_consent
to 41 43 1771 1773 I-contraception_consent
utilize 44 51 1774 1781 I-contraception_consent
one 52 55 1782 1785 I-contraception_consent
of 56 58 1786 1788 I-contraception_consent
the 59 62 1789 1792 I-contraception_consent
more 63 67 1793 1797 I-contraception_consent
effective 68 77 1798 1807 I-contraception_consent
birth 78 83 1808 1813 I-contraception_consent
control 84 91 1814 1821 I-contraception_consent
methods 92 99 1822 1829 I-contraception_consent
during 100 106 1830 1836 O
the 107 110 1837 1840 O
study 111 116 1841 1846 O
and 117 120 1847 1850 O
for 121 124 1851 1854 O
6 125 126 1855 1856 B-upper_bound
months 127 133 1857 1863 I-upper_bound
after 134 139 1864 1869 I-upper_bound
ATL 140 143 1870 1873 B-treatment
infusion 144 152 1874 1882 I-treatment

The 0 3 1883 1886 O
male 4 8 1887 1891 B-gender
partner 9 16 1892 1899 O
should 17 23 1900 1906 O
use 24 27 1907 1910 B-contraception_consent
a 28 29 1911 1912 I-contraception_consent
condom 30 36 1913 1919 I-contraception_consent

any 0 3 1920 1923 O
patient 4 11 1924 1931 O
regardless 12 22 1932 1942 O
of 23 25 1943 1945 O
sex 26 29 1946 1949 O
or 30 32 1950 1952 O
age 33 36 1953 1956 B-age
with 37 41 1957 1961 O
CD19 42 46 1962 1966 B-clinical_variable
+ 46 47 1966 1967 I-clinical_variable
B 48 49 1968 1969 B-clinical_variable
- 49 50 1969 1970 I-clinical_variable
CLL 50 53 1970 1973 I-clinical_variable
or 54 56 1974 1976 O
NHL 57 60 1977 1980 B-clinical_variable
undergoing 61 71 1981 1991 O
allogeneic 72 82 1992 2002 B-treatment
HSCT 83 87 2003 2007 I-treatment
( 88 89 2008 2009 O
Group 89 94 2009 2014 O
B 95 96 2015 2016 O
) 96 97 2016 2017 O

